Bank of New York Mellon’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.25M | Buy |
249,847
+23,155
| +10% | +$487K | ﹤0.01% | 2233 |
|
|
2025
Q1 | $3.71M | Buy |
226,692
+393
| +0.2% | +$6.44K | ﹤0.01% | 2369 |
|
|
2024
Q4 | $5.82M | Sell |
226,299
-49,932
| -18% | -$1.28M | ﹤0.01% | 2203 |
|
|
2024
Q3 | $8.75M | Sell |
276,231
-40,261
| -13% | -$1.28M | ﹤0.01% | 1999 |
|
|
2024
Q2 | $11.1M | Buy |
316,492
+95,129
| +43% | +$3.34M | ﹤0.01% | 1903 |
|
|
2024
Q1 | $9.71M | Buy |
221,363
+4,696
| +2% | +$206K | ﹤0.01% | 1970 |
|
|
2023
Q4 | $7.71M | Buy |
216,667
+20,378
| +10% | +$725K | ﹤0.01% | 2137 |
|
|
2023
Q3 | $5.3M | Buy |
196,289
+22,121
| +13% | +$597K | ﹤0.01% | 2291 |
|
|
2023
Q2 | $4.09M | Buy |
174,168
+20,267
| +13% | +$476K | ﹤0.01% | 2433 |
|
|
2023
Q1 | $2.11M | Buy |
153,901
+1,288
| +0.8% | +$17.7K | ﹤0.01% | 2779 |
|
|
2022
Q4 | $2.77M | Buy |
152,613
+31,604
| +26% | +$574K | ﹤0.01% | 2673 |
|
|
2022
Q3 | $1.81M | Buy |
121,009
+12,480
| +11% | +$186K | ﹤0.01% | 2920 |
|
|
2022
Q2 | $1.5M | Sell |
108,529
-4,377
| -4% | -$60.4K | ﹤0.01% | 2993 |
|
|
2022
Q1 | $1.26M | Sell |
112,906
-1,528
| -1% | -$17.1K | ﹤0.01% | 3165 |
|
|
2021
Q4 | $2.71M | Buy |
114,434
+4,012
| +4% | +$94.8K | ﹤0.01% | 2807 |
|
|
2021
Q3 | $2.82M | Buy |
110,422
+31,957
| +41% | +$815K | ﹤0.01% | 2796 |
|
|
2021
Q2 | $1.65M | Buy |
78,465
+29,799
| +61% | +$625K | ﹤0.01% | 3127 |
|
|
2021
Q1 | $1.14M | Buy |
48,666
+275
| +0.6% | +$6.46K | ﹤0.01% | 3250 |
|
|
2020
Q4 | $678K | Buy |
48,391
+7,235
| +18% | +$101K | ﹤0.01% | 3464 |
|
|
2020
Q3 | $517K | Buy |
41,156
+10,885
| +36% | +$137K | ﹤0.01% | 3473 |
|
|
2020
Q2 | $430K | Buy |
+30,271
| New | +$430K | ﹤0.01% | 3551 |
|